Potential antineoplastic activity of keto-C-glycosides--a new family of cytostatic agents.

Potential bioreductive alkylating agents-VI. Determination of the relationship between oxidation-reduction potential and antineoplastic activity.

Usnic acid derivatives as potential antineoplastic agents.

Using serum CA125 to assess the activity of potential cytostatic agents in ovarian cancer.

Synthesis of alkylphosphonates, a new class of antineoplastic agents.

Platinum complexes: a new class of antineoplastic agents.

Pulmonary toxicity of antineoplastic agents.

Potential cost savings associated with dose rounding antineoplastic monoclonal agents.

Possible antineoplastic agents I.

Offsetting toxicity of antineoplastic agents.

Renal toxicity of antineoplastic agents.

Antineoplastic agents from plants.

Evaluation of nephrotoxicity secondary to cytostatic agents.

Leukonychia due to cytostatic agents.

Immunomodulatory activity of two new aza alkyl phospholipid antineoplastic drugs.

Antineoplastic agents and thrombotic microangiopathy.

Antineoplastic activity of cannabinoids.

A potential CARB-pharmacophore for antineoplastic activity: part 1.

Synthesis of thieno[2,3-b]azepin-4-ones as potential antineoplastic agents.

Synthesis of novel spin-labeled derivatives of 5-FU as potential antineoplastic agents.

Application of Mannich bases to the synthesis of hydroxymethylated isoflavonoids as potential antineoplastic agents.

Antineoplastic activity of parvoviruses.

Inhibition of glyoxalase I: a possible transition-state analogue inhibitor approach to potential antineoplastic agents?

Potential central nervous system antineoplastic agents. Amides of 6-cyano-6-norlysergic acid.

Gold(III)-pyrrolidinedithiocarbamato Derivatives as Antineoplastic Agents.

Suggest Documents

Potential bioreductive alkylating agents-VI. Determination of the relationship between oxidation-reduction potential and antineoplastic activity.

Usnic acid derivatives as potential antineoplastic agents.

Using serum CA125 to assess the activity of potential cytostatic agents in ovarian cancer.

Synthesis of alkylphosphonates, a new class of antineoplastic agents.

Platinum complexes: a new class of antineoplastic agents.

Pulmonary toxicity of antineoplastic agents.

Potential cost savings associated with dose rounding antineoplastic monoclonal agents.

Possible antineoplastic agents I.

Offsetting toxicity of antineoplastic agents.

Renal toxicity of antineoplastic agents.

Antineoplastic agents from plants.

Evaluation of nephrotoxicity secondary to cytostatic agents.

Leukonychia due to cytostatic agents.

Immunomodulatory activity of two new aza alkyl phospholipid antineoplastic drugs.

Antineoplastic agents and thrombotic microangiopathy.

Antineoplastic activity of cannabinoids.

A potential CARB-pharmacophore for antineoplastic activity: part 1.

Synthesis of thieno[2,3-b]azepin-4-ones as potential antineoplastic agents.

Synthesis of novel spin-labeled derivatives of 5-FU as potential antineoplastic agents.

Application of Mannich bases to the synthesis of hydroxymethylated isoflavonoids as potential antineoplastic agents.

Antineoplastic activity of parvoviruses.

Inhibition of glyoxalase I: a possible transition-state analogue inhibitor approach to potential antineoplastic agents?

Potential central nervous system antineoplastic agents. Amides of 6-cyano-6-norlysergic acid.

Gold(III)-pyrrolidinedithiocarbamato Derivatives as Antineoplastic Agents.

Potential antineoplastic activity of keto-C-glycosides--a new family of cytostatic agents.

Recommend Documents

Follow Us